Patterns and correlates of benzodiazepine use in the French general population
- 28 August 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 60 (7), 523-529
- https://doi.org/10.1007/s00228-004-0808-2
Abstract
To investigate the prevalence of current use of benzodiazepines (BZDs) and related drugs in the French general population and factors associated with this use. National cross-sectional telephone survey conducted between 25 April 2001 and 8 May 2001 in a representative sample of non-institutionalized adults of BZD use and duration, prescriber specialty, socio-demographic data and mood and anxiety disorders, using a structured diagnostic interview. The prevalence of current use of BZD was 7.5%. It was higher among women (9.7%) than men (5.2%). It increased with age and was higher in the jobless (10.9). Duration of BZD use was more than 6 months in 75.9% of users and increased with age. Of the 711 (17.7%) subjects with at least one mood or anxiety disorder, 122 (17%) used BZD compared with180 (5.5%) of the 3296 subjects without mood or anxiety disorders. In multivariate analysis, factors associated with BZD use were age [odds ratio (OR): 3.6; 95% confidence interval (CI) 2.0–5.6], 6.5 (4.1–10.3) and 10.9 (6.9–17.1), respectively, for ages 35–44 years, 45–59 years and over 60 years compared with below 34 years, female gender (OR: 1.7; 95% CI 1.3–2.1), anxiety only (OR: 2.2; 95% CI 1.5–3.2), mood disorder only (OR: 4.4; 95% CI 2.7–7.1) or both mood and anxiety disorders (OR: 8.8; 95% CI 5.9–12.6). Despite precautions, warnings and attempts to limit use, there remains a high proportion of long-term BZD users in the general French population, especially in the elderly. Our findings add to the weight of opinion that messages concerning proper use of BZDs certainly need to be clarified and amplified.Keywords
This publication has 52 references indexed in Scilit:
- Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of diseaseBMJ, 2003
- Hazardous Benzodiazepine Regimens in the Elderly: Effects of Half-Life, Dosage, and Duration on Risk of Hip FractureAmerican Journal of Psychiatry, 2001
- A study of benzodiazepine users claiming drug-induced psychiatric morbidityNordic Journal of Psychiatry, 2001
- Oxidative and Nonoxidative Benzodiazepines and the Risk of Femur FractureJournal of Clinical Psychopharmacology, 2000
- Efficacy, Safety, and Gradual Discontinuation of Clonazepam in Panic DisorderBritish Journal of Psychology, 1999
- Clonazepam in the Treatment of Panic DisorderJournal of Clinical Psychopharmacology, 1994
- Self-reported psychotropic drug use and associated factors in a French community samplePsychological Medicine, 1992
- A Controlled Study of Alprazolam and Propranolol inJournal of Clinical Psychopharmacology, 1991
- Prevalence, frequency, and duration of hypnotic drug use among the elderly living at homeBMJ, 1988
- Psychotropic drug utilization patterns in a metropolitan populationEuropean Journal of Clinical Pharmacology, 1987